nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Nadolol—Salbutamol—chronic obstructive pulmonary disease	0.609	1	CrCrCtD
Treprostinil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0568	0.363	CbGbCtD
Treprostinil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0568	0.363	CbGbCtD
Treprostinil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.043	0.275	CbGbCtD
Treprostinil—PTGIR—pulmonary artery—chronic obstructive pulmonary disease	0.0187	0.603	CbGeAlD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00496	0.0996	CbGpPWpGaD
Treprostinil—PTGIR—respiratory system—chronic obstructive pulmonary disease	0.00314	0.101	CbGeAlD
Treprostinil—PTGIR—connective tissue—chronic obstructive pulmonary disease	0.00276	0.0893	CbGeAlD
Treprostinil—PTGIR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00253	0.0817	CbGeAlD
Treprostinil—PPARD—lung—chronic obstructive pulmonary disease	0.00217	0.0702	CbGeAlD
Treprostinil—Nadolol—ADRB2—chronic obstructive pulmonary disease	0.00172	1	CrCbGaD
Treprostinil—PTGIR—lung—chronic obstructive pulmonary disease	0.00167	0.0539	CbGeAlD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00155	0.0311	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00121	0.0243	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.00112	0.0225	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000992	0.0199	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000921	0.0185	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000903	0.0181	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000882	0.0177	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000861	0.0173	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000777	0.0156	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000721	0.0145	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000684	0.0137	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000656	0.0132	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000629	0.0126	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.000601	0.0121	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000575	0.0115	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.000561	0.0113	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000545	0.0109	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000539	0.0108	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000535	0.0107	CbGpPWpGaD
Treprostinil—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000477	0.00957	CbGpPWpGaD
Treprostinil—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000459	0.00921	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000458	0.00921	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000452	0.00908	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000448	0.00899	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000447	0.00897	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000444	0.00891	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000435	0.00874	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000427	0.00858	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000422	0.00847	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00042	0.00843	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—PLAU—chronic obstructive pulmonary disease	0.000412	0.00827	CbGpPWpGaD
Treprostinil—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00267	CcSEcCtD
Treprostinil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000405	0.00266	CcSEcCtD
Treprostinil—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00266	CcSEcCtD
Treprostinil—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000404	0.00265	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000403	0.0081	CbGpPWpGaD
Treprostinil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00265	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000401	0.00805	CbGpPWpGaD
Treprostinil—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00263	CcSEcCtD
Treprostinil—Shock—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00263	CcSEcCtD
Treprostinil—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00262	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000398	0.00798	CbGpPWpGaD
Treprostinil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.00261	CcSEcCtD
Treprostinil—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00259	CcSEcCtD
Treprostinil—Tension—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00259	CcSEcCtD
Treprostinil—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00257	CcSEcCtD
Treprostinil—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00257	CcSEcCtD
Treprostinil—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00256	CcSEcCtD
Treprostinil—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00256	CcSEcCtD
Treprostinil—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00256	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000387	0.00777	CbGpPWpGaD
Treprostinil—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00254	CcSEcCtD
Treprostinil—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00254	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000386	0.00775	CbGpPWpGaD
Treprostinil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000384	0.00252	CcSEcCtD
Treprostinil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00249	CcSEcCtD
Treprostinil—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00249	CcSEcCtD
Treprostinil—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000375	0.00246	CcSEcCtD
Treprostinil—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00245	CcSEcCtD
Treprostinil—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00245	CcSEcCtD
Treprostinil—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00245	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000371	0.00744	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00243	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000369	0.00741	CbGpPWpGaD
Treprostinil—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00242	CcSEcCtD
Treprostinil—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.00242	CcSEcCtD
Treprostinil—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00241	CcSEcCtD
Treprostinil—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00241	CcSEcCtD
Treprostinil—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00241	CcSEcCtD
Treprostinil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.0024	CcSEcCtD
Treprostinil—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.0024	CcSEcCtD
Treprostinil—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00238	CcSEcCtD
Treprostinil—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00238	CcSEcCtD
Treprostinil—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00237	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00036	0.00722	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000359	0.0072	CbGpPWpGaD
Treprostinil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.00235	CcSEcCtD
Treprostinil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00234	CcSEcCtD
Treprostinil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00234	CcSEcCtD
Treprostinil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000352	0.00232	CcSEcCtD
Treprostinil—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00232	CcSEcCtD
Treprostinil—Cough—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00231	CcSEcCtD
Treprostinil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00231	CcSEcCtD
Treprostinil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00229	CcSEcCtD
Treprostinil—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00228	CcSEcCtD
Treprostinil—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000346	0.00696	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000343	0.0069	CbGpPWpGaD
Treprostinil—Cough—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00226	CcSEcCtD
Treprostinil—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00225	CcSEcCtD
Treprostinil—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00224	CcSEcCtD
Treprostinil—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00224	CcSEcCtD
Treprostinil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00224	CcSEcCtD
Treprostinil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00224	CcSEcCtD
Treprostinil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00224	CcSEcCtD
Treprostinil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00222	CcSEcCtD
Treprostinil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00222	CcSEcCtD
Treprostinil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.0022	CcSEcCtD
Treprostinil—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000335	0.0022	CcSEcCtD
Treprostinil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000335	0.0022	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000335	0.00672	CbGpPWpGaD
Treprostinil—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000334	0.0022	CcSEcCtD
Treprostinil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00219	CcSEcCtD
Treprostinil—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000333	0.00669	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.00219	CcSEcCtD
Treprostinil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00218	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000331	0.00664	CbGpPWpGaD
Treprostinil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00216	CcSEcCtD
Treprostinil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00216	CcSEcCtD
Treprostinil—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00215	CcSEcCtD
Treprostinil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00214	CcSEcCtD
Treprostinil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00214	CcSEcCtD
Treprostinil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00212	CcSEcCtD
Treprostinil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00212	CcSEcCtD
Treprostinil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00212	CcSEcCtD
Treprostinil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00212	CcSEcCtD
Treprostinil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000321	0.00211	CcSEcCtD
Treprostinil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000321	0.00211	CcSEcCtD
Treprostinil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00032	0.0021	CcSEcCtD
Treprostinil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.0021	CcSEcCtD
Treprostinil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.0021	CcSEcCtD
Treprostinil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000319	0.0021	CcSEcCtD
Treprostinil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00207	CcSEcCtD
Treprostinil—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00206	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000312	0.00626	CbGpPWpGaD
Treprostinil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00204	CcSEcCtD
Treprostinil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00202	CcSEcCtD
Treprostinil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00202	CcSEcCtD
Treprostinil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00202	CcSEcCtD
Treprostinil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.002	CcSEcCtD
Treprostinil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.002	CcSEcCtD
Treprostinil—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000303	0.00199	CcSEcCtD
Treprostinil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00199	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00196	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00196	CcSEcCtD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00597	CbGpPWpGaD
Treprostinil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00195	CcSEcCtD
Treprostinil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00195	CcSEcCtD
Treprostinil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00194	CcSEcCtD
Treprostinil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00194	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00192	CcSEcCtD
Treprostinil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00192	CcSEcCtD
Treprostinil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00192	CcSEcCtD
Treprostinil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00191	CcSEcCtD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—EGFR—chronic obstructive pulmonary disease	0.00029	0.00583	CbGpPWpGaD
Treprostinil—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00029	0.0019	CcSEcCtD
Treprostinil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.0019	CcSEcCtD
Treprostinil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000289	0.0019	CcSEcCtD
Treprostinil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.0019	CcSEcCtD
Treprostinil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000288	0.0019	CcSEcCtD
Treprostinil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00189	CcSEcCtD
Treprostinil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00187	CcSEcCtD
Treprostinil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00186	CcSEcCtD
Treprostinil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00186	CcSEcCtD
Treprostinil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00186	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00186	CcSEcCtD
Treprostinil—Pain—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00184	CcSEcCtD
Treprostinil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00184	CcSEcCtD
Treprostinil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00184	CcSEcCtD
Treprostinil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00183	CcSEcCtD
Treprostinil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00182	CcSEcCtD
Treprostinil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00182	CcSEcCtD
Treprostinil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00181	CcSEcCtD
Treprostinil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.0018	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000274	0.0055	CbGpPWpGaD
Treprostinil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00179	CcSEcCtD
Treprostinil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00179	CcSEcCtD
Treprostinil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00179	CcSEcCtD
Treprostinil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00178	CcSEcCtD
Treprostinil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00178	CcSEcCtD
Treprostinil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00027	0.00178	CcSEcCtD
Treprostinil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00177	CcSEcCtD
Treprostinil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00177	CcSEcCtD
Treprostinil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00177	CcSEcCtD
Treprostinil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00176	CcSEcCtD
Treprostinil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00176	CcSEcCtD
Treprostinil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00176	CcSEcCtD
Treprostinil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00174	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000263	0.00529	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00173	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000262	0.00527	CbGpPWpGaD
Treprostinil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000259	0.0017	CcSEcCtD
Treprostinil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.0017	CcSEcCtD
Treprostinil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000259	0.0017	CcSEcCtD
Treprostinil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.0017	CcSEcCtD
Treprostinil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.0017	CcSEcCtD
Treprostinil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00168	CcSEcCtD
Treprostinil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00168	CcSEcCtD
Treprostinil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000256	0.00168	CcSEcCtD
Treprostinil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00168	CcSEcCtD
Treprostinil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.00167	CcSEcCtD
Treprostinil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00167	CcSEcCtD
Treprostinil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00167	CcSEcCtD
Treprostinil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00167	CcSEcCtD
Treprostinil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00167	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000252	0.00506	CbGpPWpGaD
Treprostinil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00165	CcSEcCtD
Treprostinil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00164	CcSEcCtD
Treprostinil—PPARD—Metabolism—APIP—chronic obstructive pulmonary disease	0.000248	0.00498	CbGpPWpGaD
Treprostinil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00161	CcSEcCtD
Treprostinil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00161	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000242	0.00486	CbGpPWpGaD
Treprostinil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00159	CcSEcCtD
Treprostinil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00157	CcSEcCtD
Treprostinil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00155	CcSEcCtD
Treprostinil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00155	CcSEcCtD
Treprostinil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00153	CcSEcCtD
Treprostinil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00153	CcSEcCtD
Treprostinil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00152	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00023	0.00462	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.0046	CbGpPWpGaD
Treprostinil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00149	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000226	0.00453	CbGpPWpGaD
Treprostinil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00148	CcSEcCtD
Treprostinil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00148	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000224	0.0045	CbGpPWpGaD
Treprostinil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00146	CcSEcCtD
Treprostinil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00145	CcSEcCtD
Treprostinil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00144	CcSEcCtD
Treprostinil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00143	CcSEcCtD
Treprostinil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00143	CcSEcCtD
Treprostinil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00143	CcSEcCtD
Treprostinil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000212	0.0014	CcSEcCtD
Treprostinil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00139	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000212	0.00425	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00021	0.00422	CbGpPWpGaD
Treprostinil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00137	CcSEcCtD
Treprostinil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00137	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000208	0.00417	CbGpPWpGaD
Treprostinil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00136	CcSEcCtD
Treprostinil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00136	CcSEcCtD
Treprostinil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00136	CcSEcCtD
Treprostinil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00136	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000206	0.00414	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000206	0.00413	CbGpPWpGaD
Treprostinil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00135	CcSEcCtD
Treprostinil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00135	CcSEcCtD
Treprostinil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00135	CcSEcCtD
Treprostinil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00134	CcSEcCtD
Treprostinil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00133	CcSEcCtD
Treprostinil—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000202	0.00407	CbGpPWpGaD
Treprostinil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00133	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00133	CcSEcCtD
Treprostinil—Depression—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00133	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000202	0.00405	CbGpPWpGaD
Treprostinil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00132	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.0002	0.00401	CbGpPWpGaD
Treprostinil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00131	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.00398	CbGpPWpGaD
Treprostinil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00129	CcSEcCtD
Treprostinil—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00129	CcSEcCtD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.00392	CbGpPWpGaD
Treprostinil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00128	CcSEcCtD
Treprostinil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00128	CcSEcCtD
Treprostinil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00128	CcSEcCtD
Treprostinil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00128	CcSEcCtD
Treprostinil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00128	CcSEcCtD
Treprostinil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000192	0.00385	CbGpPWpGaD
Treprostinil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00126	CcSEcCtD
Treprostinil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00125	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000189	0.0038	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000185	0.00372	CbGpPWpGaD
Treprostinil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00122	CcSEcCtD
Treprostinil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00121	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000184	0.00369	CbGpPWpGaD
Treprostinil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.0012	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000183	0.0012	CcSEcCtD
Treprostinil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00119	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000179	0.00359	CbGpPWpGaD
Treprostinil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00117	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000177	0.00355	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000177	0.00355	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000176	0.00354	CbGpPWpGaD
Treprostinil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00115	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000174	0.0035	CbGpPWpGaD
Treprostinil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00114	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000172	0.00345	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00017	0.00341	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.00017	0.00341	CbGpPWpGaD
Treprostinil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00111	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00334	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000166	0.00333	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—chronic obstructive pulmonary disease	0.000166	0.00333	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000165	0.00331	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000164	0.0033	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00327	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000162	0.00326	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000161	0.00324	CbGpPWpGaD
Treprostinil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00106	CcSEcCtD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00322	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00016	0.00322	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GC—chronic obstructive pulmonary disease	0.00016	0.00321	CbGpPWpGaD
Treprostinil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Treprostinil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00104	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000158	0.00317	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000155	0.00311	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000155	0.00311	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000153	0.00308	CbGpPWpGaD
Treprostinil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000999	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000151	0.00303	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000149	0.00298	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000148	0.00298	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000965	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000962	CcSEcCtD
Treprostinil—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000961	CcSEcCtD
Treprostinil—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00095	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00289	CbGpPWpGaD
Treprostinil—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000938	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000142	0.00286	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00285	CbGpPWpGaD
Treprostinil—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000933	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000141	0.00284	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00014	0.00282	CbGpPWpGaD
Treprostinil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000914	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000137	0.00275	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.00273	CbGpPWpGaD
Treprostinil—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000885	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000885	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000134	0.0027	CbGpPWpGaD
Treprostinil—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000882	CcSEcCtD
Treprostinil—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000875	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000129	0.0026	CbGpPWpGaD
Treprostinil—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000849	CcSEcCtD
Treprostinil—Infection—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000843	CcSEcCtD
Treprostinil—Shock—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000835	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000828	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000125	0.00251	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000125	0.00251	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000124	0.00248	CbGpPWpGaD
Treprostinil—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000809	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00238	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000773	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000772	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000117	0.00235	CbGpPWpGaD
Treprostinil—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Treprostinil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000762	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000115	0.00232	CbGpPWpGaD
Treprostinil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000747	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000113	0.00227	CbGpPWpGaD
Treprostinil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000738	CcSEcCtD
Treprostinil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000736	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000736	CcSEcCtD
Treprostinil—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000732	CcSEcCtD
Treprostinil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000732	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000109	0.00219	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000107	0.00215	CbGpPWpGaD
Treprostinil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000699	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000106	0.00213	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000694	CcSEcCtD
Treprostinil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000694	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000104	0.00209	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000104	0.00209	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000103	0.00207	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000103	0.00206	CbGpPWpGaD
Treprostinil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000671	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000671	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000101	0.00204	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000101	0.00203	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.0001	0.00201	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.71e-05	0.00195	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.58e-05	0.00192	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS2—chronic obstructive pulmonary disease	9.57e-05	0.00192	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.48e-05	0.0019	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.43e-05	0.00189	CbGpPWpGaD
Treprostinil—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.000609	CcSEcCtD
Treprostinil—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.13e-05	0.0006	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.93e-05	0.00179	CbGpPWpGaD
Treprostinil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000581	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.81e-05	0.00177	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.76e-05	0.00176	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—chronic obstructive pulmonary disease	8.74e-05	0.00176	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.73e-05	0.00175	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.67e-05	0.00174	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GCLC—chronic obstructive pulmonary disease	8.62e-05	0.00173	CbGpPWpGaD
Treprostinil—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000561	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.53e-05	0.00171	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.41e-05	0.00169	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.36e-05	0.00168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.3e-05	0.00167	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.29e-05	0.00167	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.00054	CcSEcCtD
Treprostinil—Rash—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000535	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000535	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.11e-05	0.00163	CbGpPWpGaD
Treprostinil—Headache—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000532	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.06e-05	0.00162	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—chronic obstructive pulmonary disease	8.04e-05	0.00162	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.04e-05	0.00161	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.98e-05	0.0016	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.88e-05	0.00158	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CTGF—chronic obstructive pulmonary disease	7.87e-05	0.00158	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS3—chronic obstructive pulmonary disease	7.7e-05	0.00155	CbGpPWpGaD
Treprostinil—Nausea—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000504	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.64e-05	0.00153	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.63e-05	0.00153	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.59e-05	0.00152	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.00146	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.25e-05	0.00146	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.21e-05	0.00145	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.11e-05	0.00143	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.01e-05	0.00141	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.98e-05	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.89e-05	0.00138	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.53e-05	0.00131	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.44e-05	0.00129	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.34e-05	0.00127	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.19e-05	0.00124	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.11e-05	0.00123	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.07e-05	0.00122	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.05e-05	0.00121	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.02e-05	0.00121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.96e-05	0.0012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.64e-05	0.00113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.58e-05	0.00112	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.56e-05	0.00112	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.54e-05	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.53e-05	0.00111	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.21e-05	0.00105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.19e-05	0.00104	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.09e-05	0.00102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.98e-05	0.001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.79e-05	0.000962	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.69e-05	0.000941	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.65e-05	0.000934	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.61e-05	0.000927	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—chronic obstructive pulmonary disease	4.55e-05	0.000914	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.31e-05	0.000866	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.28e-05	0.00086	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.26e-05	0.000855	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.23e-05	0.000849	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—chronic obstructive pulmonary disease	4.19e-05	0.000841	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.07e-05	0.000817	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.92e-05	0.000787	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.89e-05	0.000782	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.78e-05	0.00076	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.75e-05	0.000752	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000719	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.55e-05	0.000714	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.48e-05	0.000699	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—chronic obstructive pulmonary disease	3.43e-05	0.000688	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.3e-05	0.000663	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.000657	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.21e-05	0.000645	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.11e-05	0.000625	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.99e-05	0.000599	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.97e-05	0.000596	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.86e-05	0.000575	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.000569	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.73e-05	0.000549	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.61e-05	0.000524	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.51e-05	0.000505	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.39e-05	0.00048	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000478	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.000465	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.27e-05	0.000457	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000442	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.09e-05	0.00042	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.04e-05	0.00041	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.88e-05	0.000377	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.000376	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.84e-05	0.000369	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.000352	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.000348	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.73e-05	0.000346	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.69e-05	0.00034	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000325	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.54e-05	0.00031	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000293	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.42e-05	0.000285	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.41e-05	0.000284	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000261	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000244	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000241	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000224	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.2e-06	0.000145	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.89e-06	0.000138	CbGpPWpGaD
